In August 2002, the FDA released the Current Good Manufacturing Practices (CGMP) initiative to ensure the quality of drug products. The initiative contains minimum requirements for the methods, facilities, and controls used in manufacturing, processing, and packing of a drug product. These regulations make sure that a product is safe for use, and that it has the ingredients and strength it claims to have.5,6
AbbVie is committed to adhering to the CGMP and believes in the integrity of its manufacturing process. AbbVie is dedicated to ensuring that all Synthroid products are manufactured at the highest standards.
Note that FDA regulations require that all pharmaceutical manufactures like AbbVie abide by CGMP.